semaglutide court case Ozempic Lawsuit – July 2026 Update Novo Nordisk Wins Legal Battle

In a recent review published in the Journal of Clinical and Translational Hepatology , researchers explore the therapeutic potential and clinical insights of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Born T, Kontoghiorghe CN, Spyrou A, Kolnagou A, Kontoghiorghes GJ

Securing an oral or poster presentation at the prestigious ADA sessions highlights the medical community's interest in efsubaglutide alfa as a competitive, convenient weekly or monthly treatment alternative in a highly dynamic metabolic disease market

In 2020, medical studies highlighted that GLP-1 agonists like Ozempic could exacerbate symptoms of diabetic gastroparesis in patients with pre-existing conditions

Impact of antibiotic usage in food-producing animals on food safety and possible antibiotic alternatives